Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Nanologica AB ( (SE:NICA) ).
Syntagon AB, the contract manufacturing subsidiary of Nanologica, has created a new role of Vice President Business Development and hired industry veteran Alexandra Pichard Nielsen to drive a more sales-focused strategy. The move follows Nanologica’s recent acquisition and rebranding of Ardena Södertälje as Syntagon and is aimed at accelerating revenue growth from the unit’s SEK 77 million sales base, particularly in the Nordic region and wider Europe, by strengthening its commercial capabilities with experienced CDMO leadership.
More about Nanologica AB
Nanologica AB is a Swedish life science tools company that develops, manufactures, and sells advanced chromatographic consumables used by pharmaceutical manufacturers to purify peptide drugs such as insulin and GLP-1 analogues. Operating in a growing global niche driven by rising demand for diabetes and obesity treatments, the group also includes Syntagon, a contract manufacturer specializing in small molecules and peptides for clinical and commercial drug supply, and its shares trade on Nasdaq Stockholm.
YTD Price Performance: -21.86%
Average Trading Volume: 1,902,443
Technical Sentiment Signal: Sell
Current Market Cap: SEK198.6M
For a thorough assessment of NICA stock, go to TipRanks’ Stock Analysis page.